Home » Stocks » CDXS

Codexis, Inc. (CDXS)

Stock Price: $18.62 USD 0.10 (0.54%)
Updated December 1, 9:42 AM EST - Market open

Stock Price Chart

Key Info

Market Cap 1.10B
Revenue (ttm) 66.67M
Net Income (ttm) -20.73M
Shares Out 59.28M
EPS (ttm) -0.35
PE Ratio n/a
Forward PE 138.89
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day December 1
Last Price $18.62
Previous Close $18.52
Change ($) 0.10
Change (%) 0.54%
Day's Open 18.06
Day's Range 18.42 - 18.71
Day's Volume 203,280
52-Week Range 8.78 - 18.71

More Stats

Market Cap 1.10B
Enterprise Value 1.06B
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 59.28M
Float n/a
EPS (basic) -0.35
EPS (diluted) -0.35
FCF / Share -0.36
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 4.77M
Short Ratio 15.87
Short % of Float n/a
Beta 0.88
PE Ratio n/a
Forward PE 138.89
P/FCF Ratio n/a
PS Ratio 16.56
PB Ratio 11.76
Revenue 66.67M
Operating Income -20.95M
Net Income -20.73M
Free Cash Flow -21.31M
Net Cash 47.66M
Net Cash / Share 0.80
Gross Margin 28.43%
Operating Margin -31.41%
Profit Margin -31.10%
FCF Margin -31.96%
ROA -9.21%
ROE -21.44%
ROIC -31.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (5)

Buy 5
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$19.33*
(3.81% upside)
Low
16.0
Current: $18.62
High
23.0
Target: 19.33
*Average 12-month price target from 6 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue68.4660.5950.0248.8441.8035.3131.9288.30124107
Revenue Growth12.98%21.13%2.43%16.82%18.4%10.6%-63.85%-28.71%15.65%-
Gross Profit52.8347.9735.7039.0835.2225.5817.3757.6582.0879.12
Operating Income-12.55-11.30-22.97-8.56-7.94-19.35-41.45-30.84-15.91-7.12
Net Income-11.94-10.88-23.00-8.56-7.58-19.07-41.30-30.86-16.55-8.54
Shares Outstanding56.5352.2146.2340.6339.4438.2138.2336.7735.6724.59
Earnings Per Share-0.21-0.21-0.50-0.21-0.19-0.50-1.08-0.84-0.46-0.35
Operating Cash Flow-12.56-14.09-8.76-1.86-0.430.32-23.00-11.89-0.49-16.38
Capital Expenditures-3.73-2.77-0.98-0.85-1.18-0.14-0.94-2.93-10.74-6.98
Free Cash Flow-16.29-16.86-9.74-2.71-1.610.19-23.94-14.83-11.23-23.36
Cash & Equivalents92.2254.4932.7820.8624.0627.2025.8547.0454.9973.86
Total Debt26.120.060.30-------
Net Cash / Debt66.1054.4232.4720.8624.0627.2025.8547.0454.9973.86
Assets14979.2853.6335.6544.6548.1258.8499.97136141
Liabilities43.5622.9829.0816.5521.7721.8117.3621.5333.2333.94
Book Value10656.3124.5519.1022.8826.3141.4878.44103107
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Codexis, Inc.
Country United States
Employees 161
CEO John J. Nicols

Stock Information

Ticker Symbol CDXS
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: CDXS
IPO Date April 22, 2010

Description

Codexis discovers, develops, and sells protein catalysts. It offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides protein catalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering protein catalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.